Slovenya - Slovence - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

kemofarmacija d.d. - metformin - tableta s podaljšanim sproščanjem - metformin 1000 mg / 1 tableta - metformin

Slovenya - Slovence - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

kemofarmacija d.d. - metformin - tableta s podaljšanim sproščanjem - metformin 390 mg / 1 tableta - metformin

Slovenya - Slovence - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

sandoz d.d. - metformin; vidagliptin - filmsko obložena tableta - metformin 660 mg / 1 tableta  vidagliptin50 mg / 1 tableta; vidagliptin 50 mg / 1 tableta - metformin in vildagliptin

Slovenya - Slovence - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

sandoz d.d. - metformin, vidagliptin - filmsko obložena tableta - metformin 780 mg / 1 tableta; vidagliptin 50 mg / 1 tableta - metformin in vildagliptin

Slovenya - Slovence - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

sandoz d.d. - metformin; vidagliptin - filmsko obložena tableta - metformin 780 mg / 1 tableta  vidagliptin50 mg / 1 tableta; vidagliptin 50 mg / 1 tableta - metformin in vildagliptin

Slovenya - Slovence - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

sandoz d.d. - metformin; vidagliptin - filmsko obložena tableta - metformin 660 mg / 1 tableta  vidagliptin50 mg / 1 tableta; vidagliptin 50 mg / 1 tableta - metformin in vildagliptin

Avrupa Birliği - Slovence - EMA (European Medicines Agency)

cheplapharm arzneimittel gmbh - pioglitazone, metformin hidroklorid - diabetes mellitus, tip 2 - zdravila, ki se uporabljajo pri diabetesu - competact is indicated in the treatment of type 2 diabetes mellitus patients, particularly overweight patients, who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone.

Avrupa Birliği - Slovence - EMA (European Medicines Agency)

boehringer ingelheim - empagliflozin, metformin - diabetes mellitus, tip 2 - zdravila, ki se uporabljajo pri diabetesu - synjardy je navedeno pri odraslih, starih 18 let in več, z vrsto 2 sladkorna bolezen kot dodatek k prehrani in vadbi za izboljšanje glycaemic nadzor:pri bolnikih, neustrezno nadzorovano na njihovo maksimalno dopustne odmerek metforminom sam;pri bolnikih, neustrezno nadzorovana z metforminom v kombinaciji z drugimi glukoze-znižanje zdravil, vključno z insulina;pri bolnikih, ki se že zdravijo z kombinacijo empagliflozin in metforminom kot ločene tablete.

Avrupa Birliği - Slovence - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformin hidroklorid - diabetes mellitus, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Avrupa Birliği - Slovence - EMA (European Medicines Agency)

novartis europharm limited  - vildagliptin, metformin hidroklorid - diabetes mellitus, tip 2 - zdravila, ki se uporabljajo pri diabetesu - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.